Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 16/20 | 0.71 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA9 | Q16790 | 2/20 | 0.61 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL408478 | 0.94 | CA1 (0.68) | KIF11CA1CA2CA9 | |
| SCHEMBL31306825 | 0.92 | CA1 (0.66) | KIF11CA1CA2CA9 | |
| SCHEMBL1713465 | 0.90 | KIF11 (0.55) | KIF11CA1CA2CA9 | |
| Trifluoromethanesulfonic Acid SCHEMBL9380893 | 0.87 | CA1 (0.59) | KIF11CA1CA2CA9PPARA | |
| SCHEMBL26549483 | 0.87 | KIF11 (0.55) | KIF11CA1CA2CA9 | |
| Potassium Ion SCHEMBL28015495 | 0.85 | CA1 (0.58) | KIF11CA1CA2CA9 | |
| SCHEMBL28831379 | 0.85 | CA1 (0.58) | KIF11CA1CA2CA9 | |
| SCHEMBL24360466 | 0.84 | CA2 (0.62) | KIF11CA1CA2CA9 | |
| SCHEMBL5532552 | 0.84 | CA2 (0.62) | KIF11CA1CA2CA9 | |
| SCHEMBL3673670 | 0.84 | KIF11 (0.50) | KIF11CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | AOC1, ODC1, PIEZO1 | KIF11 3675/4885CA1 386/4885CA2 1029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.